ROY REEVES: Open Payments
NPI 1477564664 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,548 in 70 payments from 15 companies in 2025. Trend: 2023 $1,697 · 2024 $1,886 · 2025 $1,548
Food & beverage: $1,444Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $280 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $258 |
| Teva Pharmaceuticals USA, Inc. | 6 | $223 |
| Janssen Pharmaceuticals, Inc | 8 | $136 |
| E.R. Squibb & Sons, L.L.C. | 6 | $125 |
| Otsuka America Pharmaceutical, Inc. | 3 | $94 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| Lundbeck LLC | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| Alkermes, Inc. | 3 | $61 |
Products named: VRAYLAR, CAPLYTA, REXULTI, COBENFY, AUSTEDO XR, Auvelity, INVEGA SUSTENNA, SPRAVATO.
Industry payments across MS — which companies pay providers there.
